Riskpilot← Back to searchSign inGet full accessElevate Scientific AB
ABActiveOrg 5569383119HässleholmPublic relations and communication activities · NACE 7330Est. 20130 employees
Revenue 2025
SEK 1,2M
-16% vs 2024
EBITDA margin
27.7%
-19% vs 2024
Equity ratio
96.3%
Financial strength
Net profit 2025
SEK 1,3M
-26% vs 2024
| Revenue | SEK 1,2M | -16% |
| EBITDA | SEK 340K | -19% |
| Net profit | SEK 1,3M | -26% |
| Total assets | SEK 1,4M | -23% |
| Equity | SEK 1,3M | -24% |
| Employees | 0 | — |
Legal name
Elevate Scientific AB
Org number
5569383119
Legal form
Aktiebolag
NACE code
7330 · Public relations and communication activities
Founded
1 augusti 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten externa firmatecknaren
Company purpose
Företaget skall bedriva konsultverksamhet inom vetenskaplig kommunikation inbegripande rådgivning, analyser, kommunikationsplanering, information, utveckling och produktion samt därmed förenlig verksamhet. Företaget skall också bedriva undervisning inom vetenskaplig kommunikation samt därmed förenlig verksamhet.
Address
Hässleholm
Email
dcsignups@protonmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 197 | 1 921 | 1 063 | 1 454 | 1 227 |
| Staff expenses | — | −13 | −12 | −10 | −9 |
| EBITDA | 435 | 252 | 170 | 421 | 340 |
| Depreciation & amort. | −0 | — | — | — | −8 |
| EBIT | 435 | 252 | 170 | 421 | 332 |
| Net financials | 90 | −0 | 274 | 1 296 | 1 009 |
| Profit before tax | 534 | 341 | 444 | 1 827 | 1 341 |
| Tax | −92 | −71 | −36 | −112 | −69 |
| Net profit | 442 | 270 | 409 | 1 715 | 1 272 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 237 | 742 | 724 | 1 799 | 1 389 |
| Equity | 821 | 321 | 580 | 1 766 | 1 338 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 417 | 311 | 35 | 33 | 51 |
| Total debt | 417 | 311 | 35 | 33 | 51 |
EBITDA margin
27.7%
This company
15.8%
Market median
+75% vs market
20212025
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
95.1%
This company
18.4%
Market median
+417% vs market
20212025
Net profit margin
103.6%
This company
8.1%
Market median
+1179% vs market
20212025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA External Signatory | External Signatory | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Elevate Scientific AB 
Elevate Scientific Academy ABBoard members of Elevate Scientific AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mihaela-Lucia Aquelius | External Signatory | 0 companies |
| Dan-Tiberiu Csontos | Board of Directors | 0 companies |
| Ben Mihaiu Csontos | Deputy Board Member | 0 companies |